Found: 12
Select item for more details and to access through your institution.
CSF Aβ<sub>40</sub> and P-Tau<sub>181</sub> Might Differentiate Atypical from Typical AD Phenotypes: Preliminary Evidence.
- Published in:
- Neurodegenerative Diseases, 2022, v. 22, n. 2, p. 83, doi. 10.1159/000526888
- By:
- Publication type:
- Article
Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 11, p. 5691, doi. 10.1007/s00415-022-11233-5
- By:
- Publication type:
- Article
Phosphorylated tau in plasma could be a biomarker of lower motor neuron impairment in amyotrophic lateral sclerosis.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 10, p. 3697, doi. 10.1007/s10072-023-06916-4
- By:
- Publication type:
- Article
Influence of kidney function and CSF/serum albumin ratio on plasma Aβ42 and Aβ40 levels measured on a fully automated platform in patients with Alzheimer's disease.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 9, p. 3287, doi. 10.1007/s10072-023-06882-x
- By:
- Publication type:
- Article
Lower semantic fluency scores and a phonemic-over-semantic advantage predict abnormal CSF P-tau<sub>181</sub> levels in Aβ + patients within the Alzheimer's disease clinical spectrum.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 6, p. 1979, doi. 10.1007/s10072-023-06643-w
- By:
- Publication type:
- Article
Relationship between cerebrospinal fluid/serum albumin quotient and phenotype in amyotrophic lateral sclerosis: a retrospective study on 328 patients.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 5, p. 1679, doi. 10.1007/s10072-023-06604-3
- By:
- Publication type:
- Article
Cerebrospinal fluid/serum albumin quotient (Q-Alb) is not increased in Alzheimer's disease compared to neurological disease controls: a retrospective study on 276 patients.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 2, p. 709, doi. 10.1007/s10072-022-06530-w
- By:
- Publication type:
- Article
A + T ± status across MCI and dementia due to AD: a clinic-based, retrospective study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2023, v. 10, n. 1, p. 118, doi. 10.1002/acn3.51708
- By:
- Publication type:
- Article
The Frontal Assessment Battery (FAB) effectively discriminates between MCI and dementia within the clinical spectrum of neurochemically confirmed Alzheimer’s disease.
- Published in:
- Frontiers in Psychology, 2022, v. 13, p. 1, doi. 10.3389/fpsyg.2022.1054321
- By:
- Publication type:
- Article
Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis.
- Published in:
- Frontiers in Aging Neuroscience, 2023, v. 15, p. 1, doi. 10.3389/fnagi.2023.1132808
- By:
- Publication type:
- Article
Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 9, p. 1, doi. 10.1111/ene.16374
- By:
- Publication type:
- Article